2009-11-10 20:33:04 -
Genzyme Corporation - Medical Equipment - Deals and Alliances Profile - a new market research report on companiesandmarkets.com www.companiesandmarkets.com/Summary-Company-Profile/genzyme-corp ..
Genzyme Corporation (Genzyme) is a biotechnology company which is principally engaged in developing and applying technologies to encounter unmet deadly diseases. Its products and services are focused on rare disorders, kidney diseases, orthopedics, organ transplant, cancer, diagnostic and predictive testing. The company has its operations worldwide with its principal concentration in the US and the UK. Genzyme is headquartered in
Massachusetts, United States. Recently in March 2009, the company entered into an agreement with Bayer HealthCare, to acquire worldwide rights of Campath for the development and commercialization of product targeting multiple sclerosis.
The Genzyme Corporation - Medical Equipment - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
